Spanish Red Biotech Pipeline

Vivia Biotech

Personalized Medicine Test in Haematological Malignancies

Type: Diagnostic
Therapeutic area: Blood and Lymphatic systems
Cancer
Indication: Acute Myeloid Leukaemia
Phase: 5Ready to Market, 4Register, 3Clinical validation, 2Preclinical Validation, 1R+D
Studies location: Europe